Across the healthcare landscape, more and more conversations are focusing on health inequity. Specific to pulse oximetry, recent research, media, and regulatory discussions have been raising awareness ...

Medical technology giant Medtronic will purchase miniaturised ... a toolkit dedicated to providing at-home monitoring for people living with heart failure. In this issue, we unpack Ozempic ...

This includes cardiac monitors inserted into the body that record electrical activity during fainting spells and palpitations and surgical replacements for diseased heart valves. Medtronic's ...

Dr. Jeffrey Popma, the chief medical officer for the Structural Heart business unit at Medtronic, plans to retire, company ...

Medtronic's product portfolio is comprised of a variety of life-saving and life-improving medical devices that include implantable defibrillators, heart valves, insulin pumps, glucose monitoring ...

Our 2024 Women in Medtech edition features insights from Abbott's Lisa Earnhardt, Medtronic's Nina Goodheart, and more.

A month has gone by since the last earnings report for Medtronic (MDT ... Within this, Cardiac Rhythm & Heart Failure sales totaled $1.54 billion, up 7.5% year over year organically.

Tuesday, Medtronic Plc (NYSE ... Structural Heart, and Diabetes. Also Read: Abbott Labs Makes Marketing Push For New Glucose ...

Sept 19 (Reuters) - Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's (MDT.N), opens new tab patent rights in nerve ...

Medtronic has been consistently growing at ... From catheters to neurostimulators to continuous glucose monitoring devices, the company has a broad range of products in its portfolio, and it's ...

Medtronic Plc is a medical technology company ... The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded ...